{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T08:01:30Z","timestamp":1780387290240,"version":"3.54.1"},"reference-count":73,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T00:00:00Z","timestamp":1761004800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 EY024280"],"award-info":[{"award-number":["R01 EY024280"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002108","name":"Friedreich's Ataxia Research Alliance","doi-asserted-by":"publisher","award":["R01 EY031042"],"award-info":[{"award-number":["R01 EY031042"]}],"id":[{"id":"10.13039\/100002108","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.ymthe.2025.10.048","type":"journal-article","created":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T14:36:50Z","timestamp":1761316610000},"page":"771-788","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Development of an AAV-based gene therapy for the ocular phenotype of Friedreich\u2019s ataxia"],"prefix":"10.1016","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-7341-2121","authenticated-orcid":false,"given":"Heyu","family":"Tang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siddhant","family":"Gupte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaitlyn R.","family":"Calabro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"Friend","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean M.","family":"Crosson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego","family":"Fajardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zachary","family":"Kostamo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hangning","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James J.","family":"Peterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangyu","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zbynek","family":"Kozmik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cathleen M.","family":"Lutz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanford L.","family":"Boye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7312-3197","authenticated-orcid":false,"given":"Shannon E.","family":"Boye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2025.10.048_bib1","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/BF00867594","article-title":"Prevalence of hereditary ataxias and spastic paraplegias in Molise, a region of Italy","volume":"239","author":"Filla","year":"1992","journal-title":"J. Neurol."},{"key":"10.1016\/j.ymthe.2025.10.048_bib2","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/jnc.12215","article-title":"Prevalence gradients of Friedreich's ataxia and R1b haplotype in Europe co-localize, suggesting a common Palaeolithic origin in the Franco-Cantabrian ice age refuge","volume":"126","author":"Vankan","year":"2013","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ymthe.2025.10.048_bib3","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s13023-015-0328-4","article-title":"Friedreich ataxia in Norway - an epidemiological, molecular and clinical study","volume":"10","author":"Wedding","year":"2015","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.ymthe.2025.10.048_bib4","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1093\/bmb\/ldx034","article-title":"Friedreich's ataxia: clinical features, pathogenesis and management","volume":"124","author":"Cook","year":"2017","journal-title":"Br. Med. Bull."},{"key":"10.1016\/j.ymthe.2025.10.048_bib5","doi-asserted-by":"crossref","first-page":"104606","DOI":"10.1016\/j.nbd.2019.104606","article-title":"Friedreich ataxia- pathogenesis and implications for therapies","volume":"132","author":"Delatycki","year":"2019","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.ymthe.2025.10.048_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jns.2011.01.010","article-title":"Friedreich's ataxia: pathology, pathogenesis, and molecular genetics","volume":"303","author":"Koeppen","year":"2011","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.ymthe.2025.10.048_bib7","doi-asserted-by":"crossref","first-page":"7452","DOI":"10.1073\/pnas.94.14.7452","article-title":"Evolution of the Friedreich's ataxia trinucleotide repeat expansion: Founder effect and premutations","volume":"94","author":"Coss\u00e9e","year":"1997","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2025.10.048_bib8","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1002\/(SICI)1097-4598(199709)20:9<1121::AID-MUS5>3.0.CO;2-A","article-title":"GAA trinucleotide repeat expansion in variant Friedreich's ataxia families","volume":"20","author":"Cruz-Martinez","year":"1997","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.ymthe.2025.10.048_bib9","first-page":"554","article-title":"The relationship between trinucleotide (GAA) repeat length and clinical features in Friedreich ataxia","volume":"59","author":"Filla","year":"1996","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.ymthe.2025.10.048_bib10","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1002\/ana.24595","article-title":"Compound heterozygous FXN mutations and clinical outcome in friedreich ataxia","volume":"79","author":"Galea","year":"2016","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.ymthe.2025.10.048_bib11","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1136\/jnnp.63.6.780","article-title":"Trinucleotide (GAA)n repeat expansion in two families with Friedreich's ataxia with retained reflexes","volume":"63","author":"Kellett","year":"1997","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.ymthe.2025.10.048_bib12","first-page":"189","article-title":"Trinucleotide GAA repeat expansions in seven French Friedreich ataxia families","volume":"8","author":"Lucotte","year":"1997","journal-title":"Genet. Couns."},{"key":"10.1016\/j.ymthe.2025.10.048_bib13","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1086\/513887","article-title":"Phenotype correlation and intergenerational dynamics of the Friedreich ataxia GAA trinucleotide repeat","volume":"61","author":"Monros","year":"1997","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.ymthe.2025.10.048_bib14","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1001\/archneur.56.10.1201","article-title":"Molecular Pathogenesis of Friedreich Ataxia","volume":"56","author":"Pandolfo","year":"1999","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.ymthe.2025.10.048_bib15","doi-asserted-by":"crossref","DOI":"10.1080\/21688370.2025.2462357","article-title":"Frataxin deficiency and the pathology of Friedreich's Ataxia across tissues","author":"Ercanbrack","year":"2025","journal-title":"Tissue Barriers"},{"key":"10.1016\/j.ymthe.2025.10.048_bib16","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1002\/(SICI)1096-8628(19991119)87:2<168::AID-AJMG8>3.0.CO;2-2","article-title":"Clinical and Genetic Study of Friedreich Ataxia in an Australian Population","volume":"87","author":"Delatycki","year":"1999","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.ymthe.2025.10.048_bib17","doi-asserted-by":"crossref","first-page":"3521","DOI":"10.1093\/hmg\/ddn244","article-title":"The in vivo mitochondrial two-step maturation of human frataxin","volume":"17","author":"Schmucker","year":"2008","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymthe.2025.10.048_bib18","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1093\/hmg\/ddm038","article-title":"Mitochondrial frataxin interacts with ISD11 of the NFS1\/ISCU complex and multiple mitochondrial chaperones","volume":"16","author":"Shan","year":"2007","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymthe.2025.10.048_bib19","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.1038\/s41467-019-09989-y","article-title":"Structure of the human frataxin-bound iron-sulfur cluster assembly complex provides insight into its activation mechanism","volume":"10","author":"Fox","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2025.10.048_bib20","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1002\/biof.5520180219","article-title":"Friedreich's Ataxia: Disease mechanisms, antioxidant and Coenzyme Q10 therapy","volume":"18","author":"Cooper","year":"2003","journal-title":"BioFactors"},{"key":"10.1016\/j.ymthe.2025.10.048_bib21","doi-asserted-by":"crossref","first-page":"11492","DOI":"10.1073\/pnas.96.20.11492","article-title":"Deficit of in vivo mitochondrial ATP production in patients with Friedreich ataxia","volume":"96","author":"Lodi","year":"1999","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2025.10.048_bib22","doi-asserted-by":"crossref","DOI":"10.3390\/jpm11080708","article-title":"Neuro-Ophthalmological Findings in Friedreich's Ataxia","volume":"11","author":"Rojas","year":"2021","journal-title":"J. Pers. Med."},{"key":"10.1016\/j.ymthe.2025.10.048_bib23","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S0197-0186(01)00129-2","article-title":"Optic nerve degeneration and mitochondrial dysfunction: genetic and acquired optic neuropathies","volume":"40","author":"Carelli","year":"2002","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.ymthe.2025.10.048_bib24","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/S0002-9394(14)71000-1","article-title":"Ophthalmologic findings in patients with ataxia","volume":"123","author":"Rabiah","year":"1997","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.ymthe.2025.10.048_bib25","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1159\/000116277","article-title":"Visual involvement in Friedreich's ataxia: PERG and VEP study","volume":"28","author":"Pinto","year":"1988","journal-title":"Eur. Neurol."},{"key":"10.1016\/j.ymthe.2025.10.048_bib26","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.ajo.2005.03.017","article-title":"Hereditary optic neuropathies: from the mitochondria to the optic nerve","volume":"140","author":"Newman","year":"2005","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.ymthe.2025.10.048_bib27","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1038\/sj.eye.6701591","article-title":"Hereditary optic neuropathies","volume":"18","author":"Newman","year":"2004","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.ymthe.2025.10.048_bib28","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00415-009-1002-3","article-title":"Friedreich ataxia: The clinical picture","volume":"256","author":"Pandolfo","year":"2009","journal-title":"J. Neurol."},{"key":"10.1016\/j.ymthe.2025.10.048_bib29","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.2147\/JMDH.S292945","article-title":"Friedreich Ataxia: Multidisciplinary Clinical Care","volume":"14","author":"Lynch","year":"2021","journal-title":"J. Multidiscip. Healthc."},{"key":"10.1016\/j.ymthe.2025.10.048_bib30","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1093\/brain\/103.2.413","article-title":"The incidence and nature of visual pathway involvement in Friedreich's ataxia. A clinical and visual evoked potential study of 22 patients","volume":"103","author":"Carroll","year":"1980","journal-title":"Brain."},{"key":"10.1016\/j.ymthe.2025.10.048_bib31","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1001\/archneur.64.4.558","article-title":"Neurological, cardiological, and oculomotor progression in 104 patients with Friedreich ataxia during long-term follow-up","volume":"64","author":"Ribai","year":"2007","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.ymthe.2025.10.048_bib32","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/acn3.660","article-title":"Safety, pharmacodynamics, and potential benefit of omaveloxolone in Friedreich ataxia","volume":"6","author":"Lynch","year":"2019","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.ymthe.2025.10.048_bib33","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1002\/ana.25934","article-title":"Safety and Efficacy of Omaveloxolone in Friedreich Ataxia (MOXIe Study)","volume":"89","author":"Lynch","year":"2021","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.ymthe.2025.10.048_bib34","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1002\/mds.29286","article-title":"Efficacy of Omaveloxolone in Friedreich's Ataxia: Delayed-Start Analysis of the MOXIe Extension","volume":"38","author":"Lynch","year":"2023","journal-title":"Mov. Disord."},{"key":"10.1016\/j.ymthe.2025.10.048_bib35","first-page":"103","article-title":"Orphan Drugs In Development For The Treatment Of Friedreich\u2019s Ataxia: Focus On Omaveloxolone","volume":"9","author":"Ghanekar","year":"2019","journal-title":"Degener. Neurol. Neuromuscul. Dis."},{"key":"10.1016\/j.ymthe.2025.10.048_bib36","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1007\/s40263-024-01113-z","article-title":"New and Emerging Drug and Gene Therapies for Friedreich Ataxia","volume":"38","author":"Scott","year":"2024","journal-title":"CNS Drugs"},{"key":"10.1016\/j.ymthe.2025.10.048_bib37","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.3390\/ijms22041815","article-title":"Future Prospects of Gene Therapy for Friedreich\u2019s Ataxia","volume":"22","author":"Ocana-Santero","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ymthe.2025.10.048_bib38","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1089\/hum.2020.053","article-title":"Defining Transcription Regulatory Elements in the Human Frataxin Gene: Implications for Gene Therapy","volume":"31","author":"Li","year":"2020","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2025.10.048_bib39","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1016\/j.ymthe.2018.05.006","article-title":"Rapid and Complete Reversal of Sensory Ataxia by Gene Therapy in a Novel Model of Friedreich Ataxia","volume":"26","author":"Piguet","year":"2018","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2025.10.048_bib40","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1038\/nm.3510","article-title":"Prevention and reversal of severe mitochondrial cardiomyopathy by gene therapy in a mouse model of Friedreich's ataxia","volume":"20","author":"Perdomini","year":"2014","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2025.10.048_bib41","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1523\/JNEUROSCI.4549-03.2004","article-title":"Friedreich Ataxia Mouse Models with Progressive Cerebellar and Sensory Ataxia Reveal Autophagic Neurodegeneration in Dorsal Root Ganglia","volume":"24","author":"Simon","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ymthe.2025.10.048_bib42","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/jnc.12219","article-title":"Animal and cellular models of Friedreich ataxia","volume":"126","author":"Perdomini","year":"2013","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ymthe.2025.10.048_bib43","first-page":"225","article-title":"A novel GAA-repeat-expansion-based mouse model of Friedreich's ataxia","volume":"8","author":"Virmouni","year":"2015","journal-title":"DMM Dis. Models Mech."},{"key":"10.1016\/j.ymthe.2025.10.048_bib44","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1093\/hmg\/ddy427","article-title":"Correction of half the cardiomyocytes fully rescue Friedreich ataxia mitochondrial cardiomyopathy through cell-autonomous mechanisms","volume":"28","author":"Belbellaa","year":"2019","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymthe.2025.10.048_bib45","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.omtm.2020.08.018","article-title":"High Levels of Frataxin Overexpression Lead to Mitochondrial and Cardiac Toxicity in Mouse Models","volume":"19","author":"Belbellaa","year":"2020","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2025.10.048_bib46","first-page":"96","article-title":"The Impact of Visual Impairment on Quality of Life. Medical Hypothesis","volume":"5","author":"Journal","year":"2016","journal-title":"Discov. Innovation Ophthalmol."},{"key":"10.1016\/j.ymthe.2025.10.048_bib47","doi-asserted-by":"crossref","first-page":"3441","DOI":"10.1016\/j.ymthe.2023.10.001","article-title":"Intravitreal injection of a rationally designed AAV capsid library in non-human primate identifies variants with enhanced retinal transduction and neutralizing antibody evasion","volume":"31","author":"Kellish","year":"2023","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2025.10.048_bib48","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0063029","article-title":"Generation of mRx-Cre transgenic mouse line for efficient conditional gene deletion in early retinal progenitors","volume":"8","author":"Klimova","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ymthe.2025.10.048_bib49","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1093\/brain\/awn269","article-title":"Visual system involvement in patients with Friedreich's ataxia","volume":"132","author":"Fortuna","year":"2009","journal-title":"Brain."},{"key":"10.1016\/j.ymthe.2025.10.048_bib50","first-page":"131","article-title":"Visually evoked potentials in Friedreich's ataxia","volume":"32","author":"Wenzel","year":"1982","journal-title":"Adv. Neurol."},{"key":"10.1016\/j.ymthe.2025.10.048_bib51","doi-asserted-by":"crossref","first-page":"26280","DOI":"10.1073\/pnas.1902292116","article-title":"The primate model for understanding and restoring vision","volume":"116","author":"Picaud","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2025.10.048_bib52","first-page":"705","article-title":"Pou4f2 knock-in Cre mouse: A multifaceted genetic tool for vision researchers","volume":"22","author":"Simmons","year":"2016","journal-title":"Mol. Vis."},{"key":"10.1016\/j.ymthe.2025.10.048_bib53","doi-asserted-by":"crossref","first-page":"169","DOI":"10.31083\/j.fbl2706169","article-title":"Harnessing the Neuroprotective Behaviors of Muller Glia for Retinal Repair","volume":"27","author":"Pena","year":"2022","journal-title":"Front Biosci. (Landmark Ed)"},{"key":"10.1016\/j.ymthe.2025.10.048_bib54","first-page":"145","article-title":"The mouse pattern electroretinogram. Documenta ophthalmologica","volume":"115","author":"Porciatti","year":"2007","journal-title":"Adv. Ophthalmol."},{"key":"10.1016\/j.ymthe.2025.10.048_bib55","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.exer.2009.02.009","article-title":"Retinal pathway origins of the pattern ERG of the mouse","volume":"89","author":"Miura","year":"2009","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.ymthe.2025.10.048_bib56","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1038\/s41598-020-80308-y","article-title":"A novel retinal ganglion cell quantification tool based on deep learning","volume":"11","author":"Masin","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ymthe.2025.10.048_bib57","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0107416","article-title":"Cellular, molecular and functional characterisation of YAC transgenic mouse models of Friedreich ataxia","volume":"9","author":"Anjomani Virmouni","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.ymthe.2025.10.048_bib58","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s100480100118","article-title":"Rescue of the Friedreich's ataxia knockout mouse by human YAC transgenesis","volume":"3","author":"Pook","year":"2001","journal-title":"Neurogenetics"},{"key":"10.1016\/j.ymthe.2025.10.048_bib59","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0014-5793(02)02251-2","article-title":"Frataxin knockin mouse","volume":"512","author":"Miranda","year":"2002","journal-title":"FEBS Lett."},{"key":"10.1016\/j.ymthe.2025.10.048_bib60","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1242\/dmm.030502","article-title":"Early cerebellar deficits in mitochondrial biogenesis and respiratory chain complexes in the KIKO mouse model of Friedreich ataxia","volume":"10","author":"Lin","year":"2017","journal-title":"Dis. Model. Mech."},{"key":"10.1016\/j.ymthe.2025.10.048_bib61","doi-asserted-by":"crossref","DOI":"10.1242\/dmm.033415","article-title":"Correction: Early cerebellar deficits in mitochondrial biogenesis and respiratory chain complexes in the KIKO mouse model of Friedreich ataxia (doi: 10.1242\/dmm.030502)","volume":"11","author":"Lin","year":"2018","journal-title":"Dis. Model. Mech."},{"key":"10.1016\/j.ymthe.2025.10.048_bib62","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.30054","article-title":"Inducible and reversible phenotypes in a novel mouse model of Friedreich's Ataxia","volume":"6","author":"Chandran","year":"2017","journal-title":"Elife"},{"key":"10.1016\/j.ymthe.2025.10.048_bib63","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1093\/hmg\/9.8.1219","article-title":"Inactivation of the Friedreich ataxia mouse gene leads to early embryonic lethality without iron accumulation","volume":"9","author":"Cossee","year":"2000","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymthe.2025.10.048_bib64","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1113\/jphysiol.1959.sp006308","article-title":"Receptive fields of single neurones in the cat's striate cortex","volume":"148","author":"Hubel","year":"1959","journal-title":"J. Physiol."},{"key":"10.1016\/j.ymthe.2025.10.048_bib65","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.omtm.2022.02.002","article-title":"In vivo overexpression of frataxin causes toxicity mediated by iron-sulfur cluster deficiency","volume":"24","author":"Huichalaf","year":"2022","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2025.10.048_bib66","doi-asserted-by":"crossref","DOI":"10.3390\/genes14081654","article-title":"Finding an Appropriate Mouse Model to Study the Impact of a Treatment for Friedreich Ataxia on the Behavioral Phenotype","volume":"14","author":"Bouchard","year":"2023","journal-title":"Genes (Basel)"},{"key":"10.1016\/j.ymthe.2025.10.048_bib67","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1038\/mt.2014.139","article-title":"Vector design Tour de Force: integrating combinatorial and rational approaches to derive novel adeno-associated virus variants","volume":"22","author":"Marsic","year":"2014","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2025.10.048_bib68","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1016\/j.ymthe.2020.04.002","article-title":"Novel AAV44.9-Based Vectors Display Exceptional Characteristics for Retinal Gene Therapy","volume":"28","author":"Boye","year":"2020","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2025.10.048_bib69","doi-asserted-by":"crossref","DOI":"10.1371\/annotation\/99ee1789-a658-4fb0-8593-40a40e9f344a","article-title":"Targeting photoreceptors via intravitreal delivery using novel, capsid-mutated AAV vectors","volume":"8","author":"Kay","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ymthe.2025.10.048_bib70","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1089\/hum.2018.193","article-title":"Somatic Gene Editing of GUCY2D by AAV-CRISPR\/Cas9 Alters Retinal Structure and Function in Mouse and Macaque","volume":"30","author":"McCullough","year":"2019","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2025.10.048_bib71","doi-asserted-by":"crossref","DOI":"10.3791\/58571-v","article-title":"Using optical coherence tomography and optokinetic response as structural and functional visual system readouts in mice and rats","author":"Dietrich","year":"2019","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.ymthe.2025.10.048_bib72","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1089\/hum.2012.125","article-title":"The human rhodopsin kinase promoter in an AAV5 vector confers rod- and cone-specific expression in the primate retina","volume":"23","author":"Boye","year":"2012","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2025.10.048_bib73","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2024.109881","article-title":"Optimizing retinal ganglion cell nuclear staining for automated cell counting","volume":"242","author":"Lin","year":"2024","journal-title":"Exp. Eye Res."}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152500162500869X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152500162500869X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T16:39:16Z","timestamp":1770223156000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S152500162500869X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":73,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S152500162500869X"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2025.10.048","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of an AAV-based gene therapy for the ocular phenotype of Friedreich\u2019s ataxia","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2025.10.048","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}]}}